Atlas Trials

Long-Term Safety Study of Inhaled Insulin: An Up to Four-Year Extension of Therapy in Subjects With Type 1 or Type 2 Diabetes Mellitus

Clinical trial NCT00143247 · TERMINATED

Trial details

NCT number
NCT00143247
Sponsor
Pfizer
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Diabetes Mellitus
Start date
2003-03-01
Primary completion
2008-01-01
Enrollment
173

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.